Clinical trials: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Viral Infection
Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV)
This study aimed to analysis the characteristics of MERS transmission and the effect of our institutional personal protective equipment on the controlling the MERS at a tertiary Korean Hospital.
- Trial name
- MKU (NCT02605109)
- Testing
- Risk of MERS infection
- Volunteers
- 200 people
- Sponsor
- Konkuk University Medical Center
Respiratory Distress Syndrome (& [Hyaline Membrane Disease])
Anti-MERS-CoV Convalescent Plasma Therapy
Since the first report of the Middle East Respiratory Syndrome Corona virus (MERS- CoV) in September 2012, more than 800 cases have been reported to the World Health Organization (WHO) with substantial mortality.
- Trial name
- NCT02190799
- Testing
- Convalescent plasma
- Where
- Saudi Arabia
- Sponsor
- King Abdullah International Medical Research Center